By
Adrianne Appel2023-04-28T19:22:00
Mastercard said it is under investigation by the Department of Justice’s (DOJ) Antitrust Division regarding the company’s debit card program.
In March, the DOJ delivered a civil investigative demand (CID) to Mastercard concerning its debit program and competition with other payment networks and technologies, the company said in a first-quarter filing with the Securities and Exchange Commission on Thursday.
The DOJ is probing whether Mastercard violated Sections 1 or 2 of the Sherman Antitrust Act, the company said. The Sherman Act gives federal agencies the power, under certain circumstances, to curb commercial activity that is viewed as anticompetitive.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2023-03-09T21:13:00Z By Adrianne Appel
Five corporate board members resigned after being flagged by the Department of Justice for potentially violating the antitrust provisions of the Clayton Act.
2023-01-05T22:10:00Z By Adrianne Appel
The Federal Trade Commission proposed a rule that would ban new and existing noncompete clauses by employers, claiming they stifle healthy competition, dampen wages, and raise the price of goods.
2022-04-06T20:07:00Z By Jaclyn Jaeger
The prompt self-reporting of any involvement in an antitrust cartel will be a key consideration going forward in receiving leniency from the Department of Justice.
2026-01-22T17:32:00Z By Neil Hodge
Nick Ephgrave, director of the U.K.’s main anti-corruption enforcement agency, the Serious Fraud Office, will retire at the end of March—about halfway through his appointed five-year term. Experts say he leaves the agency in a lot better position than he joined it in September 2023.
2026-01-16T20:32:00Z By Oscar Gonzalez
The U.S. Federal Trade Commission finalized its order against General Motors and its OnStar subsidiary over the improper usage of geolocation and driving behavior data of drivers.
2026-01-16T17:49:00Z By Adrianne Appel
Kaiser Health affiliates have agreed to pay more than $556 million to settle allegations originally made by whistleblowers that they ignored compliance department warnings and unlawfully reworked diagnoses for Medicare patients in order to receive higher payments from the federal government.
Site powered by Webvision Cloud